| Hang Seng Index | 26.840 HKD | +0.040 | +0.149% | 297.90M | 7.94B | 26.826 (+0.051%) HKD as at 2025/09/10 | | |
| Hang Seng China Enterprises | 95.580 HKD | -0.140 | -0.146% | 55.35M | 5.26B | 94.787 (+0.837%) HKD as at 2025/09/09 | | |
| Hang Seng TECH Index | 5.810 HKD | +0.015 | +0.259% | 660.64M | 3.80B | 5.796 (+0.242%) HKD as at 2025/09/10 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 6.215 HKD | +0.030 | +0.485% | 136.21M | 829.28M | 6.190 (+0.402%) HKD as at 2025/09/10 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.340 HKD | -0.006 | -0.446% | 362.70M | 495.74M | 1.347 (-0.527%) HKD as at 2025/09/10 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.812 HKD | +0.002 | +0.110% | 123.07M | 226.45M | 1.813 (-0.061%) HKD as at 2025/09/10 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.260 HKD | -0.005 | -0.080% | 21.49M | 132.58M | 6.255 (+0.078%) HKD as at 2025/09/10 | | |
| Hang Seng TECH Index | 12.480 HKD | +0.050 | +0.402% | 8.63M | 106.89M | 12.287 (+1.568%) HKD as at 2025/09/09 | | |
| Hang Seng TECH Index | 5.905 HKD | +0.015 | +0.255% | 17.15M | 100.13M | 5.813 (+1.579%) HKD as at 2025/09/09 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 17.320 HKD | -0.580 | -3.240% | 5.06M | 86.36M | 17.939 (-3.451%) HKD as at 2025/09/10 | | |
| CSI 300 | 51.300 HKD | +0.940 | +1.867% | 1.62M | 82.68M | 50.320 (+1.948%) HKD as at 2025/09/10 | | |
| FTSE China A50 | 16.160 HKD | +0.270 | +1.699% | 4.97M | 79.90M | 15.793 (+2.324%) HKD as at 2025/09/09 | | |
| Hang Seng China Enterprises | 10.770 HKD | +0.010 | +0.093% | 6.16M | 66.15M | 10.735 (+0.323%) HKD as at 2025/09/09 | | |
| London Gold Fixing Price | 2,605.000 HKD | -10.000 | -0.382% | 10.93K | 28.49M | N/A | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 7.255 HKD | +0.545 | +8.122% | 3.66M | 25.88M | 6.541 (+10.914%) HKD as at 2025/09/09 | | |
| SSE Science and Technology Innovation Board 50 Index | 12.200 HKD | +0.570 | +4.901% | 1.63M | 19.74M | 11.604 (+5.139%) HKD as at 2025/09/10 | | |
| FTSE China A50 | 15.020 HKD | +0.240 | +1.624% | 1.14M | 16.94M | 14.782 (+1.612%) HKD as at 2025/09/10 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 19.490 HKD | -0.200 | -1.016% | 853.90K | 16.73M | 19.675 (-0.938%) HKD as at 2025/09/09 | | |
| Hang Seng High Dividend Yield | 30.960 HKD | +0.200 | +0.650% | 482.52K | 14.89M | 30.364 (+1.963%) HKD as at 2025/09/09 | | |
| Solactive China Healthcare Disruption Index | 4.160 HKD | -0.156 | -3.614% | 3.19M | 13.11M | 4.300 (-3.251%) HKD as at 2025/09/10 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 13.980 HKD | +0.180 | +1.304% | 836.30K | 11.67M | 13.737 (+1.771%) HKD as at 2025/09/10 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.460 HKD | +0.170 | +1.652% | 1.10M | 11.52M | 10.280 (+1.755%) HKD as at 2025/09/10 | | |
| SSE Science and Technology Innovation Board 50 Index | 8.835 HKD | +0.370 | +4.371% | 1.29M | 11.26M | 8.474 (+4.264%) HKD as at 2025/09/10 | | |
| CSI Hong Kong Dividend | 38.180 HKD | +0.160 | +0.421% | 267.80K | 10.20M | 38.166 (+0.037%) HKD as at 2025/09/10 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.740 HKD | +0.162 | +3.539% | 1.79M | 8.36M | 4.608 (+2.869%) HKD as at 2025/09/10 | | |
| FTSE US Treasury 20+ Years Index | 69.980 HKD | +0.360 | +0.517% | 118.17K | 8.27M | 69.728 (+0.361%) HKD as at 2025/09/09 | | |
| MSCI China A 50 Connect Index (net total return index) | 28.160 HKD | +0.840 | +3.075% | 248.00K | 6.97M | 27.306 (+3.126%) HKD as at 2025/09/10 | | |
| Solactive China Biotech Index NTR | 78.540 HKD | -2.620 | -3.228% | 82.91K | 6.44M | 81.730 (-3.903%) HKD as at 2025/09/09 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.746 HKD | -0.022 | -0.584% | 1.45M | 5.33M | 3.761 (-0.394%) HKD as at 2025/09/10 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.640 HKD | +0.010 | +0.275% | 1.40M | 5.09M | 3.647 (-0.181%) HKD as at 2025/09/09 | | |